Two (E)‐2‐arylidene‐1,4‐di‐p‐tosyl‐1,2,3,4‐tetrahydroquinoxaline compounds: supramolecular frameworks built with C—H...O and C—H...π(arene) hydrogen bonds and π–π stacking interactions

The pyrazine ring in two N‐substituted quinoxaline derivatives, namely (E)‐2‐(2‐methoxybenzylidene)‐1,4‐di‐p‐tosyl‐1,2,3,4‐tetrahydroquinoxaline, C₃₀H₂₈N₂S₂O₅, (II), and (E)‐methyl 2‐[(1,4‐di‐p‐tosyl‐1,2,3,4‐tetrahydroquinoxalin‐2‐ylidene)methyl]benzoate, C₃₁H₂₈N₂S₂O₆, (III), assumes a half‐chair conformation and is shielded by the terminal tosyl groups. In the molecular packing of the compounds, intermolecular C—H...O hydrogen bonds between centrosymmetrically related molecules generate dimeric rings, viz. R₂²(22) in (II) and R₂²(26) in (III), which are further connected through C—H...π(arene) hydrogen bonds and π–π stacking interactions into novel supramolecular frameworks.     

A 1,3,2‐ox­aza­borolidine dimer derived from (S)‐α,α‐di­phenyl­prolinol

The reaction of (S)‐α,α‐di­phenyl­prolinol with an excess of borane–tetra­hydro­furan complex yields a stable crystalline material with the composition C₃₄H₃₈B₂N₂O₂, which features a borane adduct of a spiro­cyclic structure with two ox­aza­borolidine rings joined by a central tetrahedral B atom. This dimeric ox­aza­borolidine complex, viz. 3,3,3′,3′‐tetra­phenyl‐1,1′‐spiro­bi(3a,4,5,6‐tetra­hydro‐3H‐pyrrolo­[1,2‐c][1,3,2]­ox­azaborole)–7‐borane, is the dominant product under various reaction conditions; its crystal structure is consistent with ¹¹B, ¹H and ¹³C NMR and IR analyses.     

Supramolecular structures of 5‐[3‐(4‐methyl­phenyl)‐ and 5‐[3‐(4‐chloro­phenyl)‐2‐propenyl­idene]‐2,2‐di­methyl‐1,3‐dioxane‐4,6‐dione

2,2‐Di­methyl‐5‐[3‐(4‐methyl­phenyl)‐2‐propenyl­idene]‐1,3‐di­ox­ane‐4,6‐dione, C₁₆H₁₆O₄, crystallizes in the triclinic space group , with two mol­ecules in the asymmetric unit. These mol­ecules and a centrosymmetrically related pair, linked together by weak C—H?O hydrogen bonds, form a tetramer. 5‐[3‐(4‐Chloro­phenyl)‐2‐propenyl­idene]‐2,2‐di­methyl‐1,3‐dioxane‐4,6‐dione, C₁₅H₁₃ClO₄, also crystallizes in the triclinic space group , with one mol­ecule in the asymmetric unit. Centrosymmetrically related mol­ecules are linked together by weak C—H?O hydrogen bonds to form dimers which are further linked by yet another pair of centrosymmetrically related C—H?O hydrogen bonds to form a tube which runs parallel to the a axis.     

16‐(4‐Cyano­benzyl­idene)‐17‐oxo­androst‐5‐en‐3β‐ol

In the title compound, 4‐(3β‐hydroxy‐17‐oxoandrost‐5‐en‐16‐ylidenemethyl)benzonitrile, C₂₇H₃₁NO₂, rings A and C of the steroid nucleus are in chair conformations. The central six‐membered ring B is in an 8β,9α‐half‐chair conformation, while the five‐membered ring D adopts a 13β,14α‐half‐chair conformation. The cyano­benzyl­idene moiety has an E configuration with respect to the carbonyl group at position C17. The dihedral angle between the planes of the steroid nucleus and the cyano­benzyl­idene moiety is 22.61 (15)°. Intermolecular O—H⃛N hydrogen bonds formed between the hydroxyl group of the steroid and the N atom of the cyano­benzyl­idene moiety of symmetry‐related mol­ecules link the steroid mol­ecules into chains which run parallel to the b axis.     

Derivatives of 4‐(2‐hydro­xy­lphenyl)‐2‐phenyl‐2,3‐di­hydro‐1,5‐benzothiazepine

In the structures of 2‐(4‐chloro­phenyl)‐4‐(2‐hydroxyphenyl)‐2,3‐di­hydro‐1,5‐benzo­thia­zepine, C₂₁H₁₆ClNOS, 4‐(2‐hy­droxy­phenyl)‐2‐(4‐tolyl)‐2,3‐di­hydro‐1,5‐ben­zo­thia­zepine, C₂₂H₁₉NOS, and 4‐(2‐hydroxyphenyl)‐2‐(3‐methoxy­phenyl)‐2,3‐di­hydro‐1,5‐benzo­thia­zepine, C₂₂H₁₉NO₂S, the central seven‐membered heterocyclic rings adopt twist‐boat conformations in which the N atoms are involved in strong intramolecular hydrogen bonds with the hydroxyl H atoms, resulting in six‐membered rings.     

A novel three‐dimensional copper(II) coordination polymer with 1,4‐bis(1,2,4‐triazol‐1‐ylmeth­yl)benzene and thio­cyanate

In the title complex, poly[copper(II)‐di‐μ₂‐thio­cyanato‐μ₂‐1,4‐bis­(1,2,4‐triazol‐1‐ylmeth­yl)benzene], [Cu(NCS)₂(C₁₂H₁₂N₆)]_n, the Cu^II atom lies on an inversion centre in a tetra­gonally distorted octa­hedral environment. Four N atoms from thio­cyanate and 1,4‐bis­(1,2,4‐triazol‐1‐ylmeth­yl)benzene (bbtz) ligands fill the equatorial positions, and S atoms from symmetry‐related thio­cyanate ligands fill the axial positions. The benzene ring of the bbtz ligand lies about an inversion centre. Single thio­cyanate bridges link the Cu^II atoms into two‐dimensional sheets containing an unprecedented 16‐membered [Cu₄(μ‐NCS‐N:S)₄] ring. The bbtz ligands further link the two‐dimensional sheets into a three‐dimensional network.     

A dinuclear uranium(IV) complex of the chelating ligand 1,2,3,4‐tetra­methyl‐5‐(2‐pyridyl)­cyclo­penta­diene

The ligand 1,2,3,4‐tetra­methyl‐5‐(2‐pyridyl)­cyclo­penta­diene (cp*py) forms a dinuclear complex with U^IV, i.e. di‐μ‐oxo‐bis­{chloro­(diethyl ether‐κO)[(η⁵,κN)‐1,2,3,4‐tetra­methyl‐5‐(2‐pyridyl)­cyclo­penta­dienyl]uranium(IV)}, [U₂Cl₂O₂(C₁₄H₁₆N)₂(C₄H₁₀O)₂], in which cp*py acts as a chelating ligand, being bound to the metal atom by the cyclo­penta­dienyl unit and also by the N atom of the pyridyl ring.     

Comparison of conventional and synchrotron X‐ray structure deter­minations of the adduct 1,2,4,5‐tetrahydroxybenzene–2,5‐dihydroxy‐1,4‐benzoquinone (1/1) and a conventional X‐ray structure determination of 1,2,4,5‐tetrahydroxybenzene monohydrate

The X‐ray structure of 1,2,4,5‐tetra­hydroxy­benzene (benzene‐1,2,4,5‐tetrol) monohydrate, C₆H₆O₄·H₂O, (I), reveals columns of 1,2,4,5‐tetra­hydroxy­benzene parallel to the b axis that are separated by 3.364 (12) and 3.453 (11) Å. Molecules in adjacent columns are tilted relative to each other by 27.78 (8)°. Water mol­ecules fill the channels between the columns and are involved in hydrogen‐bonding interactions with the 1,2,4,5‐tetra­hydroxy­benzene mol­ecules. The crystal structure of the adduct 1,2,4,5‐tetra­hydroxy­benzene–2,5‐di­hydroxy‐1,4‐benzo­quinone (1/1), C₆H₆O₄·C₆H₄O₄, (II), reveals alternating mol­ecules of 1,2,4,5‐tetra­hydroxy­benzene and 2,5‐di­hydroxy‐1,4‐benzo­quinone (both lying on inversion centers), and a zigzag hydrogen‐bonded network connecting mol­ecules in three dimensions. For compound (II), the conventional X‐ray determination, (IIa), is in very good agreement with the synchrotron X‐ray determination, (IIb). When differences in data collection temperatures are taken into account, even the displacement parameters are in very good agreement.     

(Z)‐7‐Chloro‐3‐[(3‐chloro­phenyl)­methyl­idene]‐4‐p‐tosyl‐3,4‐di­hydro‐2H‐1,4‐benzoxazine

In the title compound, C₂₂H₁₇Cl₂NO₃S, the mol­ecule is a substituted 3,4‐di­hydro‐2H‐1,4‐benzoxazine compound which has three phenyl rings which are essentially planar. The 3,4‐di­hydro‐2H‐oxazine part of the mol­ecule is fused to the benzo ring and has a half‐boat conformation; the dihedral angle between the planar part of the oxazine ring and the benzo ring is 10.2 (2)°. The (3‐chloro­phenyl)­methyl­idene substituent has a Z configuration in relation to the ring N atom of the oxazine moiety. Interestingly, the p‐toluenesulfonyl (p‐tosyl) substituent on the ring N atom protrudes away from the 3‐­chloro­phenyl substituent thus avoiding any steric interaction.     

rac‐(Z)‐Ethyl 2‐bromo‐2‐[(3R,5R)‐3‐bromo‐5‐methyl­tetra­hydro­furan‐2‐yl­idene]acetate

In the title compound, C₉H₁₂Br₂O₃, a (tetra­hydro­furan‐2‐yl­idene)acetate, the double bond has the Z form. In the tetra­hydro­furan group, the relative configuration of the Br atom in the 3‐position and the methyl group in the 5‐position is anti. The compound crystallizes with two independent mol­ecules per asymmetric unit and, in the crystal structure, the individual mol­ecules are linked to their symmetry‐equivalent mol­ecules by C—H⋯O hydrogen bonds, so forming centrosymmetric hydrogen‐bonded dimers.     

Di­spiro­[fluorene‐9,5′‐[1,2,3,4]­tetra­thia­ne‐6′,9′′‐fluorene]

The tetra­thia­ne ring of the title compound, C₂₆H₁₆S₄, has a chair conformation and the mol­ecule has approximate C₂ symmetry. Each of the two fluorene ring systems is virtually planar, with the ring planes intersecting at an angle of 67.58 (5)°. This novel compound has been formed as a side product from the treatment of 9H‐fluorene‐9‐thione with methyl N‐[(benzyl­idene)­phenyl]­glycinate in the presence of LiBr and 1,6‐di­aza­bi­cyclo­[5.4.0]­un­decane.     

Four bis(1‐chloro‐2,2,4,4‐tetramethyl‐3‐oxocyclobutan‐1‐yl)oligosulfanes

The four oligosulfanes, bis(1‐chloro‐2,2,4,4‐tetra­methyl‐3‐oxo­cyclo­butan‐1‐yl)­disulfane, C₁₆H₂₄Cl₂O₂S₂, (III), 1,3‐bis(1‐chloro‐2,2,4,4‐tetra­methyl‐3‐oxo­cyclo­butan‐1‐yl)­trisulfane, C₁₆H₂₄Cl₂O₂S₃, (V), 1,4‐bis(1‐chloro‐2,2,4,4‐tetra­methyl‐3‐oxo­cyclo­butan‐1‐yl)­tetrasulfane, C₁₆H₂₄Cl₂O₂S₄, (VII), and 1,6‐bis(1‐chloro‐2,2,4,4‐tetra­methyl‐3‐oxo­cyclo­butan‐1‐yl)­hexasul­fane, C₁₆H₂₄Cl₂O₂S₆, (VIII), all have similar geometric parameters, with the C—C bond lengths involving the chloro‐substituted cyclo­butanyl C atom being elongated to about 1.59 Å. There are two mol­ecules in the asymmetric units of the tri‐ and tetrasulfanes, and the mol­ecules in the latter compound have local C₂ symmetry. The mol­ecule of the hexasulfane has crystallographic C₂ symmetry. Most of the cyclo­butanyl rings are not perfectly planar and have slight but varying degrees of distortion towards a flattened tetrahedron. The polysulfane chain in each structure has a helical conformation, with each additional S atom in the chain adding approximately one quarter of a turn to the helix.     

The diastereoisomers methyl 5‐(S)‐[2‐(R)/(S)‐methoxycarbonyl)‐2,3,4,5‐tetrahydropyrrol‐1‐ylcarbonyl]‐1‐(4‐methylphenyl)‐4,5‐dihydropyrazole‐3‐carboxylate

The title diastereoisomers, methyl 5‐(S)‐[2‐(S)‐methoxy­carbonyl)‐2,3,4,5‐tetra­hydro­pyrrol‐1‐yl­carbonyl]‐1‐(4‐methyl­phenyl)‐4,5‐di­hydro­pyrazole‐3‐carboxyl­ate and methyl 5‐(S)‐[2‐(R)‐methoxycarbonyl)‐2,3,4,5‐tetrahydropyrrol‐1‐ylcarbonyl]‐1‐(4‐methyl­phenyl)‐4,5‐di­hydro­pyrazole‐3‐carboxylate, both C₁₉H₂₃N₃O₅, have been studied in two crystalline forms. The first form, methyl 5‐(S)‐[2‐(S)‐methoxy­carbonyl)‐2,3,4,5‐tetrahydropyrrol‐1‐ylcarbonyl]‐1‐(4‐methylphenyl)‐4,5‐di­hydro­pyrazole‐3‐carboxyl­ate–methyl 5‐(S)‐[2‐(R)‐methoxy­carbonyl)‐2,3,4,5‐tetra­hydro­pyrrol‐1‐yl­carbonyl]‐1‐(4‐methylphenyl)‐4,5‐dihydropyrazole‐3‐carboxylate (1/1), 2(S),5(S)‐C₁₉H₂₃N₃O₅·2(R),5(S)‐C₁₉H₂₃N₃O₅, contains both S,S and S,R isomers, while the second, methyl 5‐(S)‐[2‐(S)‐methoxycarbonyl)‐2,3,4,5‐tetrahydro­pyrrol‐1‐ylcarbonyl]‐1‐(4‐methyl­phenyl)‐4,5‐di­hydro­pyrazole‐3‐carboxyl­ate, 2(S),5(S)‐C₁₉H₂₃N₃O₅, is the pure S,S isomer. The S,S isomers in the two structures show very similar geometries, the maximum difference being about 15° on one torsion angle. The differences between the S,S and S,R isomers, apart from those due to the inversion of one chiral centre, are more remarkable, and are partially due to a possible rotational disorder of the 2‐­(methoxycarbonyl)tetrahydropyrrole group.     

1:1 Adduct of (S,S)‐4‐amino‐3,5‐bis­(1‐hydroxy­ethyl)‐1,2,4‐triazole with (S,S)‐1,2‐bis­(2‐hydroxy­propionyl)­hydrazine stabilized by eight hydrogen bonds

The structure of the cocrystallized 1:1 adduct of (S,S)‐4‐amino‐3,5‐bis­(1‐hydroxy­ethyl)‐1,2,4‐triazole and (S,S)‐1,2‐bis­(2‐hydroxy­propionyl)­hydrazine, C₆H₁₂N₄O₂·C₆H₁₂N₂O₄, has tetra­gonal symmetry. All eight O‐ and N‐bound H atoms are involved in inter­molecular hydrogen bonds, resulting in infinite zigzag chains of the triazole mol­ecules, with the hydrazine mol­ecules filling the gaps between the chains and completing a three‐dimensional hydrogen‐bonded array.     

Di‐μ‐hydro­xo‐bis­(diiso­propyl­gallium)–1,4,8,11‐tetra­methyl‐1,4,8,11‐tetra­aza­cyclo­tetra­decane (1/1)

The hydro­lysis product [Ga₂(C₃H₇)₄(OH)₂]·C₁₄H₃₂N₄, derived from the tetrakis­(triiso­propyl­gallium)–1,4,8,11‐tetra­methyl‐1,4,8,11‐tetra­aza­cyclo­tetra­decane (1/1) adduct, consists of a centrosymmetric [ⁱPr₂Ga(μ‐OH)]₂ unit hydrogen bonded through the hydroxyl group to a nitro­gen on an adjacent centrosymmetric 1,4,8,11‐tetra­methyl‐1,4,8,11‐tetra­aza­cyclo­tetra­decane molecule, resulting in the generation of a molecular chain through the crystal.     

Supra­molecular motifs in 1‐(2‐cyano­ethyl)thymine and 1‐(3‐cyano­propyl)­thymine

In both 1‐(2‐cyano­ethyl)thymine [systematic name: 3‐(5‐methyl‐2,4‐dioxo‐1,2,3,4‐tetra­hydro­pyrimidin‐1‐yl)propane­nitrile], C₈H₉N₃O₂, (I), and 1‐(3‐cyano­propyl)thymine [systematic name: 4‐(5‐methyl‐2,4‐dioxo‐1,2,3,4‐tetra­hydro­pyrimidin‐1‐yl)butane­nitrile], C₉H₁₁N₃O₂, (II), the core of the supra­molecular structure is formed by centrosymmetric dimers generated by N—H⋯O hydrogen bonds. Further weak hydrogen bonds of C—H⋯O and C—H⋯N types generate mol­ecular tapes and sheets that resemble those in uracil and its methyl derivatives. The steric hindrance that arises from the cyano­alkyl substituents perturbs the conformations of the tapes and sheets.     

4‐(3,17‐Dioxoandrost‐4‐en‐16‐ylidenemethyl)benzonitrile

The title compound, C₂₇H₂₉NO₂, has the outer six‐membered ring in a sofa conformation, while the central rings are in chair conformations. The five‐membered ring adopts a slightly distorted 13β,14α‐half‐chair conformation. The cyano­benzyl­idene moiety has an E configuration with respect to the carbonyl group at position 17.     

16‐(4‐Iso­propyl­benzyl­idene)­androst‐4‐ene‐3,17‐dione

In the title compound, C₂₉H₃₆O₂, the outer cyclohexene ring of the steroid nucleus has a conformation that lies about half‐way between a half‐chair and an envelope, while the central and outer cyclo­hexane rings of the steroid nucleus have slightly distorted chair conformations. The steroidal cyclo­pentane ring adopts a 13β,14α‐half‐chair conformation. The benzyl­idene moiety has an E configuration with respect to the carbonyl group on the cyclo­pentane ring. The dihedral angle between the mean planes of the steroid nucleus and the benzyl­idene moiety is 35.54 (9)°. The packing of the mol­ecules is assumed to be dictated mainly by weak intermolecular C—H⋯O interactions.     

Precursor of a β‐lactamase inhibitor: allyl (4S,8S,9R)‐10‐[(E)‐ethyl­idene]‐4‐methoxy‐11‐oxo‐1‐aza­tri­cyclo­[7.2.0.03,8]­undec‐2‐ene‐2‐carboxyl­ate

The molecular structure of the title tricyclic compound, C₁₇H₂₁NO₄, which is the immediate precursor of a potent synthetic inhibitor {Lek157: sodium (8S,9R)‐10‐[(E)‐ethyl­idene]‐4‐methoxy‐11‐oxo‐1‐aza­tri­cyclo­[7.2.0.0^3,8]­undec‐2‐ene‐2‐carboxyl­ate} with remarkable potency, provides experimental evidence for the previously modelled relative position of the fused cyclo­hexyl ring and the carbonyl group of the β‐lactam ring, which takes part in the formation of the initial tetrahedral acyl–enzyme complex. In this hydro­phobic mol­ecule, the overall geometry is influenced by C—H?O intramolecular hydrogen bonds [3.046 (4) and 3.538 (6) Å, with corresponding normalized H?O distances of 2.30 and 2.46 Å], whereas the mol­ecules are interconnected through intermolecular C—H?O hydrogen bonds [3.335 (4)–3.575 (5) Å].     

Bis­(di‐μ‐acetato‐aqua{2‐[N‐ethyl‐N‐(2‐hydroxy‐4‐methyl­benzyl)­amino­methyl]‐1‐methyl­benz­imid­az­ole}­nickel)­nickel(II) tetra­hy­drate

The previously unknown title compound, tetra‐μ‐ace­tato‐1:2κ²O;1:2κ²O:O′;­2:3κ²O;­2:3κ²O:O′‐di­aqua‐1κO,3κO‐bis­(μ‐2‐{[N‐ethyl‐N‐(2‐hy­droxy‐5‐methylbenzyl)­am­ino]­methyl}‐1‐methyl‐1H‐benz­imid­az­ole)‐1κ³N³,N,O:2κO;3κ³N³,N,O:2κO‐tri­nickel(II) tetra­hy­drate, [Ni₃(C₁₈H₂₂N₃O)₂(C₂H₃O₂)₄(H₂O)₂]·­4H₂O, (I), is a centrosymmetric linear trinuclear nickel(II) complex, where the Ni atoms are in an octahedral coordination and the ligand heteroatoms act so as to model amino acid residues.